An Observational and Analytical Study to Evaluate Heart Diseases with ECG,2D Echo and Fasting Lipid Profile
- Conditions
- Health Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I019- Acute rheumatic heart disease, unspecifiedHealth Condition 3: I209- Angina pectoris, unspecifiedHealth Condition 4: I110- Hypertensive heart disease with heart failureHealth Condition 5: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereHealth Condition 6: I089- Rheumatic multiple valve disease,unspecified
- Registration Number
- CTRI/2023/08/056260
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Diagnosed cases of Heart Diseases like Angina and Myocardial Infarction, Heart Failure, Rheumatic Heart Disease, Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, Carditis, Aortic aneurysms etc. patients with symptoms of Hridroga.
2 Patients diagnosed with post covid cardiac disorder.
3 Duration of disease â?? 0-10 yrs,10 - 20 yrs ,20 - 30 yrs,30-40 yrs. (with 10 years duration)
1 Patients diagnosed with symptoms of Krimaj Hridroga.
2 Patient having major ailments of other systems. Eg CA of any organs, Hepatitis B and C, Pregnancy, TB etc. at the time of enrolling the patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method As this is an Observational study & i am going to assess the relation between types of hridroga based on ECG, Echo & Fasting lipid profile with duration of disease.There may be some changes which i will get or there may be nothing significant finding. Here we are going to establish the relation in hridroga types on the basis of symptoms and investigationsTimepoint: 18 MONTH
- Secondary Outcome Measures
Name Time Method As this is observational study I am going to observe the relation between the duration of onset of the study & its impact on the ECG & 2D echo & fasting lipid profileTimepoint: 12 MONTHS